Clinical Trial Management System Market Research Report: By Type (Enterprise CTMS and On-Site CTMS), Delivery Model (Web-Based [Hosted CTMS], Licensed Enterprise, Cloud-Based CTMS [SaaS]), Component (Software, Service and Hardware), End-User (Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Contract Research Organizations and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
ID: MRFR/HCIT/1522-HCR | February 2021 | Region: Global | 90 pages
Speak to Analyst
Request a Free Sample
Clinical Trial Management System Market Scenario
Clinical Trial Management System Market is expected to grow significantly over the forecast period. The market held a valuation of USD 732.5 Million in 2018 and is projected to account for USD 1,631.3 Million by 2025, registering a CAGR of 12.0% over the forecast period.
The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market during the forecast period.
Various other factors, such as the low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the clinical trial management system market.
However, growing clinical trial failure rates and lengthy clinical trial approval time can impede the clinical trial management system market growth over the forecast period.
Segmentation
The Clinical Trial Management System Market has been segmented based on type, delivery model, component, end user, and region.
The global market for clinical trial management system, by type, has been segmented into enterprise CTMS and on-site CTMS.
The delivery model segment consists of web-based (hosted CTMS), licensed enterprise, and cloud-based CTMS (SaaS).
On the basis of component, the market has been segmented into software, service, and hardware.
The end users of the market have been segmented into pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The clinical trial management system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European clinical trial management system market has been segmented into Western Europe and Eastern Europe. Western Europe has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The clinical trial management system market in Asia-Pacific has been classified as Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The clinical trial management system market in the Middle East & Africa has been divided into the Middle East and Africa.
Regional Market Summary
Global Clinical Trial Management System Market Share (%), by Region, 2018 
Sources: MRFR Analysis
The Americas dominated the global market for a clinical trial management system owing to the increasing investments in research and development of CTMS by major companies and government organizations. In 2019, according to ClinicalTrials.gov database, there were total 322,282 studies registered for clinical trials, wherein and 34% cases registered from the US and 49% from other countries.
In 2018, Europe stood second in the global clinical trial management system market. The growing healthcare IT sector and high accuracy level of information provided by the clinical trial management system is expected to drive the growth of the market. Germany is expected to have the largest share in the European market for clinical trial management systems.
Asia-Pacific is expected to register the fastest growth in clinical trial management system market throughout the forecast period due to the growing customer base for CTMS solutions, growing demand for CMTS in the key markets around the globe, and the favorable government policies for the growth of healthcare IT sector in the region. The increasing sedentary lifestyle is countries in Asia-Pacific fuels the market growth in this region. Moreover, the presence of countries such as China, India, and Japan is expected to have positive impact on the market growth.
On the other hand, the Middle East and Africa held the least share in the global clinical trial management system market due to the lack of awareness and low income, especially within Africa.
Key Players
Some of the key players in the Global Clinical Trial Management System Market are Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others.
Market Segmentation
Clinical Trial Management System Market, by Type
- Enterprise CTMS
- On-Site CTMS
Clinical Trial Management System Market, by Delivery Model
- Web-Based (Hosted CTMS)
- Licensed Enterprise
- Cloud-Based CTMS (SaaS)
Clinical Trial Management System Market, by Component
- Software
- Service
- Hardware
Clinical Trial Management System Market, by End User
- Pharmaceutical and Biopharmaceutical Companies
- Medical Device Manufacturers
- Contract Research Organizations
- Others
Intended Audience
- Pharmaceutical Manufacturers and Suppliers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Contract Research Organizations (CROs)
- Government organizations
- Independent Research Laboratories
- Research and Development (R&D) Companies
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size |
|
| CAGR | 12.0% (2019-2025) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Type, Component, End-User and Region |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others |
| Key Market Opportunities | The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market |
| Key Market Drivers | The low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market. |
Frequently Asked Questions (FAQ) :
The clinical trial management system market is expected to reach USD 1,631.3 million by 2025.
The clinical trial management system market was valued at USD 732.5 million in 2018.
The clinical trial management system market is expected to exhibit a CAGR of 12% from 2019 to 2025.
The alarming cases of chronic diseases is the major driver of the global clinical trial management system market.
Failure of clinical trials and the lengthy approval times of therapeutics are major challenges of the global clinical trial management system market.
Mednet Solutions, PAREXEL, iWeb Technologies, Medidata Solutions, IBM, ERT, eClinForce, Inc., Arisglobal, Forte Research Systems Inc., DSG, Oracle, DZS Software Solutions, Bioclinica, Bio-Optronics, Veeva Systems, Mastercontrol, and Datatrak are major players of the global clinical trial management system market.
